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In Brief GATA-2 is a regulator of hematopoiesis. Hewitt et al. find that a GATA-2-regulated enhancer, controlling expression of an SAM domain protein, promotes red blood cell regeneration and hence survival of anemia in mice. This enhancer is part of a family of anemia-responsive elements, which may orchestrate the response to anemia.
INTRODUCTION
Transcription factor complexes occupy vast ensembles of cisregulatory elements to establish/maintain genetic networks controlling physiological processes such as hematopoiesis (Fujiwara et al., 2009; Li et al., 2011; Shen et al., 2012b; Wilson et al., 2010; Yu et al., 2009 ). In hematopoiesis, two Gata2 ciselements (Grass et al., 2003 (Grass et al., , 2006 Johnson et al., 2012 Johnson et al., , 2015 induce expression of the master regulatory transcription factor GATA-2 (Tsai et al., 1994) . A GATA-2-occupied Gata2 intronic enhancer (+9.5) containing an E-box-8 bp spacer-AGATAA composite element (E-box-GATA element) is required for hematopoietic stem cell (HSC) emergence from hemogenic endothelium in the mouse embryo (Gao et al., 2013) . A GATA-2-occupied enhancer 77 kb upstream of Gata2 (À77), which contains several GATA motifs (Grass et al., 2006) , confers myeloerythroid progenitor differentiation potential, without affecting HSC emergence (Johnson et al., 2015) . Insufficient GATA-2 levels/activity resulting from GATA2 coding or +9.5 enhancer mutations underlie hematologic diseases, including primary immunodeficiencies that frequently progress to myelodysplastic syndrome (MDS), acute myeloid leukemia (AML) (Dickinson et al., 2011; Hahn et al., 2011; Hsu et al., 2011; Ostergaard et al., 2011) , and pediatric MDS/AML independently of immunodeficiency (Wlodarski et al., 2016) . Since GATA factor occupancy of a GATA motif in chromatin does not predict GATA factor-dependent regulation of the linked gene Hewitt et al., 2015; Sanalkumar et al., 2014) , many questions remain unanswered regarding mechanisms conferring GATA-2 activity.
Given the essential +9.5 enhancer activity, we reasoned that a cohort of cis-elements with sequence and molecular attributes resembling the +9.5 (+9.5-like) are also critical. Prioritization of GATA-2-occupied E-box-GATA elements with attributes resembling the +9.5 enhancer, and gene editing in G1E mouse erythroid precursor cells revealed sites that regulate their endogenous loci and seemingly similar sites that do not (Hewitt et al., 2015; Tanimura et al., 2015) . The functional sites included a conserved intronic enhancer (Samd14-Enh) at the largely unstudied, GATA-2-occupied Samd14 gene (Hewitt et al., 2015) . SAMD14 is expressed in HSC, megakaryocyte erythrocyte progenitor (MEP) and committed erythroid progenitors (Chen and Lodish, 2014; Hewitt et al., 2015) , downregulated in colorectal cancer and adenocarcinoma (Shen et al., 2012a; Sun et al., 2008) , and polymorphisms associated with blood platelet volume are linked to altered SAMD14 expression (Fehrmann et al., 2011) . A genome-wide screen for human genetic variants linked to hematologic phenotypes correlated a polymorphism within the SAMD14 5 0 UTR with platelet distribution width (Astle et al., 2016) . Samd14 is downregulated $20 fold in myeloid progenitors lacking the Gata2 À77 enhancer (Johnson et al., 2015) . Short hairpin RNA (shRNA)-mediated downregulation of Samd14 in mouse fetal liver hematopoietic stem and progenitor cells (HSPCs) reduced stem cell factor (SCF)-induced c-Kit signaling and myelo-erythroid progenitor levels (Hewitt et al., 2015) .
Conforming to a type I feedforward loop (Shoval and Alon, 2010) , GATA-2 directly activates Kit and Samd14 transcription, and Samd14 promotes SCF-induced c-Kit receptor tyrosine kinase signaling (Hewitt et al., 2015) . Given the vital GATA-2 and c-Kit functions in diverse hematopoietic cells, it is instructive to consider the biological contexts of Samd14 function. c-Kit signaling is an important determinant of erythropoiesis (Munugalavadla and Kapur, 2005; Paulson et al., 2011) . Kit or SCF mutations cause macrocytic anemia (Nocka et al., 1989) and impair recovery from acute anemia (Broudy et al., 1996; Harrison and Russell, 1972) . By lysing red blood cells, phenylhydrazine (PHZ) induces acute hemolytic anemia, triggering c-Kit + erythroid stress progenitor expansion at extramedullary sites, including spleen (Lenox et al., 2005; Paulson et al., 2011) . These stress progenitors express GATA-2 and the E-box-binding basic-helix-loop-helix protein Scl/TAL1. In response to hypoxia, SCF, and BMP-4, the stress progenitors generate erythrocytes (Harandi et al., 2010; Perry et al., 2007) . Signaling-defective Kit mutant mice exhibit macrocytic anemia to varying degrees, and their response to anemic stress is impaired (Agosti et al., 2009; Perry et al., 2007) . Endothelial cell-derived SCF supports stress erythropoiesis, as conditional SCF deletion in splenic endothelial cells suppresses recovery from anemia (Inra et al., 2015) . Since stress erythropoiesis regenerates red blood cells in anemia (Bozzini et al., 1970) , during recovery from surgery (Schlitt et al., 1995) , chemotherapy , bone marrow transplantation (Harandi et al., 2010) , and viral infection (Subramanian et al., 2008) , ensuring the integrity of stress erythropoiesis mechanisms is critical.
Here, we demonstrate that targeted deletion of Samd14-Enh in mice strongly reduced Samd14 expression in bone marrow and spleen and establish it as a GATA-2-and anemia-activated (G2A) enhancer conferring survival in severe anemia. Mechanistic analyses indicated that Samd14-Enh is the founding member of an ensemble of anemia-responsive enhancers essential for red blood cell regeneration during severe anemia, but dispensable for steady-state hematopoiesis.
RESULTS
GATA Factor-Activated Enhancer Regulates Expression of a Sterile Alpha Motif Domain Protein In Vivo GATA-2 and Scl/TAL1 occupy Samd14-Enh 2.5 kb downstream of the Samd14 transcription start site in G1E mouse erythroid precursor cells ( Figure 1A ). The intronic Samd14-Enh site harbors a composite E-box-GATA element (Hewitt et al., 2016; Hoang et al., 2016; Wadman et al., 1997) resembling the +9.5 site that increases Gata2 expression in hemogenic endothelium and triggers HSPC genesis in the mouse embryo (Gao et al., 2013) . Genome editing revealed that Samd14-Enh increases Samd14 transcription in G1E cells (Hewitt et al., 2015) . To determine if Samd14-Enh regulates Samd14 transcription in vivo and if Samd14 functions in a Scl/TAL1-GATA-2-dependent mechanism, we used TALENs to generate a C57BL/6N mouse strain with a 33 bp deletion lacking the E-box and GATA motifs (Samd14-Enh À/À ) ( Figure 1B , left). Although Samd14-Enh
embryos were born at Mendelian ratios ( Figure 1B , right), Samd14 mRNA was 23-fold lower in Samd14-Enh À/À versus wild-type (WT) bone marrow ( Figure 1C ); Samd14 expression in brain was unaffected ( Figure 1C ). Samd14 primary transcripts (intron 9) were 11-fold lower (p = 0.0019) in Samd14-Enh À/À versus WT. Thus, Samd14-Enh activates Samd14 transcription in vivo ( Figure 1C ). While Samd14 mRNA levels were indistinguishable in Lin À Sca1 + Kit + (LSK) cells sorted from WT and Samd14-Enh À/À bone marrow, it was reduced significantly in Samd14-Enh À/À common myeloid progenitor (CMP), granulocyte macrophage progenitor (GMP), and MEP populations versus WT ( Figure 1D ). As Samd14 downregulation reduces mouse fetal liver myeloerythroid progenitor CFUs (Hewitt et al., 2015) , we assessed bone marrow cellularity of Samd14-Enh À/À mice. No differences were detected in the percentages of bone marrow LSK, CMP, GMP, or MEP populations ( Figures 1E and S1A ). Using the erythroid lineage markers CD71 and Ter119, the percentages of cells at distinct stages of erythroid maturation (R1-R5 populations) (Zhang et al., 2003) were unaltered in Samd14-Enh À/À bone marrow ( Figures 1F and S1B ). The expression of genes deregulated upon shRNA-mediated Samd14 downregulation in cultured fetal liver erythroid precursors (Kit, Ptpn11, Rab1, SlamF1) (Hewitt et al., 2015) was unaffected in Samd14-Enh À/À bone marrow ( Figure 1G ). In addition, cellularity and expansion potential were unaffected upon ex vivo culture of fetal liver erythroid precursors (Figures 1H and S1C) . In 8-week-old WT and Samd14-Enh À/À mice, complete blood count (CBC) hematological parameters were indistinguishable ( Figure 1I , Table  S1 ). Although Samd14-Enh strongly increased Samd14 transcription in vivo ( Figure 1C ), its deficiency did not affect steady-state hematopoiesis.
GATA-2-and Anemia-Activated Enhancer Confers Survival in Severe Anemia Since Samd14-Enh was not required for steady-state hematopoiesis, we tested whether Samd14-Enh and Samd14 are important in PHZ-induced hemolytic anemia. After two daily administrations of 60 mg/kg PHZ to induce severe anemia, 15 of 16 mutant animals died before day 6; all WT mice survived (median survival = 4 days, log rank test p = 0.0001) (Figure 2A ). A single PHZ injection (100 mg/kg) in Samd14-Enh À/À mice produced anemia but was not lethal, and this dose was used for subsequent mechanistic analyses. Three days after PHZ injection, Samd14-Enh À/À spleen weight was 15% less than WT (p = treatment, WT and Samd14-Enh À/À control spleens generated similar numbers of burst-forming unit-erythroid (BFU-E) colonies in methylcellulose containing erythropoietin (Epo), SCF, interleukin (IL)-3, and IL-6 ( Figure 2D ). However, Samd14-Enh
splenocytes generated 2.9-fold fewer (p = 0.0015) BFU-E versus WT 48 hr after PHZ injection and 2.9-fold fewer (p = 0.009) BFU-E versus WT 72 hr after PHZ injection ( Figure 2D ). In Epo-containing methylcellulose, spleens from vehicle-treated mice generated similar numbers of BFU-E in WT and Samd14-Enh Figure 2E ). Three days after PHZ treatment, Samd14-Enh
splenocytes generated 15% fewer (p = 0.048) BFU-E versus WT; colony-forming unit-erythroid (CFU-E) were unaffected ( Figure 2E ). Samd14-Enh increased Samd14 expression in bone marrow, and we tested whether it also regulates Samd14 in spleen in normal and stress erythropoiesis contexts. Samd14 mRNA levels were 20-fold lower in Samd14-Enh À/À versus WT spleen ( Figure 3A ). PHZ increased Samd14 mRNA 36-fold (p = 0.002) in WT spleen, but not brain, and Samd14-Enh deletion abrogated this response ( Figure 3A) . Expression of genes flanking Samd14 (Ppp1r9b and Pdk2) was similar in WT and Samd14-Enh À/À spleen ( Figure S2 ). PHZ increased Ppp1r9b expression similarly in WT and Samd14-Enh
, indicating that Samd14-Enh selectively activates Samd14 transcription. As Samd14 protein had not been described, targeted mass spectrometry was used to test whether the changes in Samd14 mRNA affect Samd14 protein levels. Analysis of three Samd14 peptides revealed that PHZ increased Samd14 levels 3.6-fold (p = 0.0001) ( Figure 3B ). Samd14 was 16-fold lower (p < 0.0001) in Samd14-Enh versus WT spleen. PHZ did not affect Samd14 levels in the mutant cells (Figure 3B) . Since no Samd14 antibody had been reported, we generated a rabbit anti-murine Samd14 polyclonal antibody. The antibody detected a major 55 kDa band in spleen from PHZ-treated mice and weak 55 and 69 kDa bands in vehicle-treated spleen (Figure 3C ). The 55 kDa protein was not detected in spleen from vehicle or PHZ-treated Samd14-Enh À/À mice ( Figure 3C ). An anti-Samd14 shRNA expressed in G1E cells downregulated the 55 kDa protein ( Figure 3D ). PHZ increased GATA-2 in WT and Samd14-Enh À/À spleen ( Figure 3E ).
Samd14 and Gata2 share nearly identical intronic E-box-GATA elements that mediate enhancer activity (Hewitt et al., 2015) . As PHZ increased Samd14 and GATA-2 mRNA and protein levels, we devised an allele-specific transcription assay to test whether Samd14-Enh and Gata2 +9.5 are anemia-responsive enhancers ( Figure 3F ). We quantitated allele-specific primary transcripts from WT and mutant alleles in spleen from PHZ-treated (100 mg/kg) Samd14-Enh +/À mice. PHZ increased Samd14 primary transcripts from the WT allele 22-fold (p = 0.003) ( Figure 3F ). While mutant allele expression was higher in PHZ-versus vehicle-treated spleen, Samd14 primary transcripts were 10-fold lower in PHZ-treated mutant versus WT spleen (p = 0.004) ( Figure 3F ). To test whether anemia-induced Gata2 expression required the +9.5 enhancer, we quantitated allele-specific primary transcripts from control and PHZ-treated spleens of Gata2 +9.5 +/À mice. PHZ increased Gata2 primary transcripts from the WT allele 6.5-fold (p = 0.013); expression from the mutant allele was unaffected ( Figure 3F ).
We tested whether anemia-dependent increases in Samd14 expression can be generalized to distinct anemia models. Phlebotomy-induced anemia (41% decrease in hematocrit) increased Samd14 mRNA (16.5-fold, p = 0.023) in WT, but not Samd14-Enh À/À , spleen ( Figure 3I ). Bone marrow transplantation results in a similarly reduced hematocrit at early times post-transplant, requiring short-term radioprotective cells to generate new erythrocytes (Harandi et al., 2010) . At 10 days post-transplant, Samd14 mRNA increased 24-fold (p = 0.0004) ( Figure 3H ), and Gata2 mRNA increased 2.1-fold (p = 0.02) in the spleen ( Figure 3I ). Thus, three distinct modes of inducing acute anemia elevate Samd14 expression.
To identify splenic cells in which anemia increases Samd14 expression, we used fluorescence-activated cell sorting (FACS) with anti-CD71 and -Ter119 antibodies to isolate erythroid cell populations ( Figure 4A (B) Targeted mass spectrometry using three distinct Samd14 peptides in WT and Samd14-Enh À/À spleen from vehicle-treated and PHZ-treated animals.
Peptide 1, SASQESTLSDDSTPPSSSPK; peptide 2, SLDEDEPPPSPLAR; peptide 3, QVDGPQLLQLDGSK.
(C) Western blotting of Samd14 in WT and Samd14-Enh À/À spleen from vehicle-and PHZ-treated animals.
(D) Western blot analysis of Samd14 in G1E cells retrovirally infected with an shRNA targeting Samd14 mRNA (shSamd14) relative to control shRNA (shControl).
(E) Top, western blotting of GATA-2 in WT and Samd14-Enh À/À spleen from vehicle-and PHZ-treated animals. Bottom, densitometric quantitation (n = 3).
(F) (Top) Experimental strategy to test allele-specific transcription changes in Samd14-Enh and Gata2 +9.5 heterozygous spleen following a 3 day PHZ treatment. Forward primers exclusively anneal to WT or mutant Enh À alleles of primary transcripts, and reverse primers anneal to both alleles. (Bottom) Allele-specific qRT-PCR analysis of Samd14 and Gata2 primary transcripts from Samd14-Enh +/À and Gata2 +9.5 +/À mice, respectively, in control (n = 3) and PHZ-treated (n = 4) spleen.
(G) Hematocrit (left) and Samd14 mRNA (right) in WT and Samd14-Enh À/À spleen from control and phlebotomized animals (n = 4 in each group).
(H) Samd14 mRNA levels in total spleen at 2, 4, 6, 8, 10, 12, and 14 days post-transplantation (n = 2). (I) Gata2 mRNA levels in total spleen at 2, 4, 6, 8, 10, 12, and 14 days post-transplantation (n = 2). Statistical significance represented by mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001. As c-Kit signaling can positively autoregulate Kit expression (Hewitt et al., 2015; Zhu et al., 2011) , and Samd14 downregulation attenuates SCF/c-Kit signaling in fetal liver erythroid precursors (Hewitt et al., 2015) , we tested whether Samd14-Enh deletion affects Kit signaling during stress erythropoiesis in the spleen. Phospho-flow cytometry was used to quantitate SCF/ c-Kit-induced AKT and ERK phosphorylation (pAKT and pERK). Using splenic cells from control and PHZ-treated mice (3 days), magnetic beads were used to deplete Ter119 Figure 5D ). In bone marrow, SCF-induced pAKT and pERK indistinguishably in WT and Samd14-Enh À/À cells ( Figure S5 ), revealing a selective Samd14 function to promote anemia-dependent c-Kit signaling in the spleen.
GATA-2-and Anemia-Activated Enhancers Constitute a Vital Sector of the Hematopoietic Stem and Progenitor
Cell Cistrome Samd14-Enh promotes red blood cell regeneration, thereby conferring survival in severe anemia. The E-box-GATA composite element at Samd14-Enh nucleates a multi-protein complex comprised of GATA-1/2, Scl/TAL1, LDB1, and LMO2 to mediate transcription of hematopoietic loci (Hewitt et al., 2016 Figure 6A ). To establish whether anemia influences Samd14-Enh chromatin accessibility, we analyzed a 1 kb region surrounding the composite element. Formaldehyde-assisted isolation of regulatory elements (FAIRE) (Hewitt et al., 2015; Sanalkumar et al., 2014; Simon et al., 2012 ) was used to quantify chromatin accessibility in CD71 + Ter119 À splenic cells from control and PHZ-treated mice. This analysis revealed a striking increase (p = 0.0003) in chromatin accessibility directly upstream of the composite element ( Figure 6B ), which was abrogated by Samd14-Enh deletion ( Figure 6C ). We tested whether other +9.5-like components of the HSPC cistrome are also regulated by anemia ( Figure 6D ). Loci (Bcl2l1, Sox6, Trip4, Bag2, Inpp5d, and Pstpip1) were selected based on a prioritized ranking of chromatin features and biological criteria (Hewitt et al., 2015) . Although anemia was reported to increase Bcl2l1 and Sox6 expression (Dumitriu et al., 2010; Koulnis et al., 2012) , the underlying mechanisms are unclear. Other loci harboring +9.5-like sites have not been studied in erythropoiesis. Thyroid hormone receptor interactor 4 (Trip4) encodes a subunit of the tetrameric nuclear activating signal co-integrator 1 (ASC-1) complex (Jung et al., 2002) . BCL2-associated athanogene-2 (Bag2) is a co-chaperone that opposes Hsp70 function (Takayama et al., 1999) . Inositol polyphosphate 5-phosphatase (Inpp5d or Ship1) modulates signaling through the B cell receptor (Ono et al., 1996) and promotes myeloid cell proliferation (Chen et al., 2015) . Proline-serine-threonine phosphatase-interacting protein 1 gene (Pstpip1) encodes a cytoskeletal adapter (Spencer et al., 1997) , and mutations cause pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome (Wise et al., 2002) .
Bcl2l1, Trip4, Sox6, Bag2, Inpp5d , and Pstpip1 +9.5-like sites ( Figure 6D ) exhibit mouse-human conservation, DNase hypersensitivity, and GATA-2 regulation, based on analyses of WT versus +9.5 À/À fetal liver (Hewitt et al., 2015) . In G1E cells, GATA-2 occupied these sites, but not the negative control Necdin promoter ( Figure 6E ). Scl/TAL1 and Lmo2 occupied E-box-GATA composite elements at Gata2, Samd14, Bcl2l1, and Trip4 in Lin À Kit + hematopoietic progenitors; Scl/TAL1 occupied Sox6 and Bag2 composite elements ( Figure S6B ). By contrast, Inpp5d and Pstpip1 composite elements were not GATA-2, Scl/TAL1 or Lmo2 occupied ( Figure S6B ). Consistent with the established paradigm in which only certain GATA-2-regulated genes are GATA-1 regulated (Dore et al., 2012; Fujiwara et al., 2009; Katsumura et al., 2017) , a subset of +9.5-like loci (Samd14, Bcl2l1, and Bag2) are GATA-1 regulated in G1E cells; others (Sox6, Trip4, Inpp5d, and Pstpip1) are GATA-1 insensitive ( Figure S7A ). To test whether the +9.5-like loci are anemia responsive, we quantified gene expression in spleen from control and PHZ-treated mice. PHZ increased Bcl2l1, Sox6, Trip4, and Bag2 expression, but not Inpp5d or Pstpip1, in sorted CD71 + Ter119 À ( Figure 6F ) and CD71 + Ter119
À Kit + cells ( Figure 6G ), indicating that expression was altered in erythroid progenitors and did not reflect anemia-dependent cellularity changes. In addition to Samd14-Enh, PHZ increased accessi- bility at Gata2 +9.5, Bcl2l1, Bag2, Trip4, and Sox6 +9.5-like sites, but not Pstpip1 or Inpp5d ( Figure 6H ). Thus, GATA-2 and anemia increase chromatin accessibility and activity of a subset of E-box-GATA element-containing enhancers. Anemia dramatically increases (up to 1,000 fold) blood Epo levels (Bunn, 2013) . Epo is commonly used to treat anemia and is a vital erythropoiesis-stimulating agent physiologically and upon hypoxia. To test whether anemia-dependent Epo generation constitutes a component of the Samd14-Enh anemia-responsive mechanism, we stimulated serum-starved PHZ-treated splenocytes with Epo for 4 hr. Epo increased Samd14 expression in WT, but not Samd14-Enh À/À cells (Figure 6I) . Thus, Samd14-Enh is required for Epo-dependent Samd14 expression. Expression of Bcl2l1, Bag2, Trip4, and Sox6, but not Pstpip1 or Inpp5d, was also stimulated by Epo ( Figure S7B ). These findings implicate Epo signaling as one component of the multi-component anemia-responsive enhancer mechanism.
DISCUSSION
Mono-methylated histone H3 at lysine 4, acetylated histone H3 at K27, p300, and accessible chromatin are canonical enhancer attributes used to infer the existence of enhancers in genomes (Bulger and Groudine, 2011; Smith and Shilatifard, 2014) . In the context of GATA factors, many prospective enhancers bearing these attributes are either not GATA-factoroccupied or can be deleted from a genome with little to no functional consequence DeVilbiss et al., 2014; Fujiwara et al., 2009; Sanalkumar et al., 2014; Snow et al., 2010 Snow et al., , 2011 Tanimura et al., 2015) . Previously, we used a multi-parametric prioritization strategy to identify GATA-2-regulated enhancers containing E-box-GATA elements in G1E cells (Hewitt et al., 2015) . Here, we analyzed one such enhancer in vivo and demonstrated that anemia activates Samd14-Enh, which promotes red blood cell regeneration in stress erythropoiesis, thereby conferring survival in severe anemia. Samd14-Enh represents the founding member of a G2A enhancer family.
Although Samd14-Enh has attributes resembling the Gata2 +9.5 enhancer required for HSPC genesis, steady-state hematopoiesis is normal in Samd14-Enh Statistical significance represented by mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001.
tions in a cell-type-specific manner to activate an ensemble of +9.5-like elements, including Samd14-Enh. Samd14-Enh cell-type specificity is illustrated by its importance for Samd14 transcription in bone marrow and splenic myeloerythroid progenitors, but not in multipotent LSK cells or in brain. The essential Samd14-Enh activity controls stress erythropoiesis, which extends E-box-GATA element functionality beyond that of developmental and steady-state hematopoiesis. Three independent modes of acute anemia activate Gata2 and Samd14 transcription in the spleen, and GATA-2 regulates Samd14 expression. This anemia-protective circuit conforms to a type I coherent feedforward loop, which predicts that establishment of the circuit requires a persistent stimulus, while stimulus loss rapidly inactivates the circuit ( Figure 7A ) (Shoval and Alon, 2010) .
Mass spectrometric and western blotting analyses provided evidence that Samd14-Enh controls expression of the SAM domain protein Samd14. Samd14-Enh was required for anemiadependent induction of SCF/c-Kit signaling in spleen. Mammalian proteomes contain several hundred SAM domain proteins, and SAM domains are implicated in protein, RNA, and lipid binding (Kim and Bowie, 2003) . Kit signaling-defective knockin mice can have phenotypes resembling Samd14-Enh À/À mice (Agosti et al., 2009; Perry et al., 2007) , suggesting that Samd14 activity to enhance SCF/c-Kit signaling in vivo confers survival in severe anemia.
Our results indicate that anemia activates a subset of GATA-2-regulated E-box-GATA element enhancers to elevate transcription of the linked genes. Since the GATA-2 target gene Samd14 promotes red blood cell regeneration in severe anemia, and GATA-2 target genes Bcl2l1 (Koulnis et al., 2012) and Sox6 (Dumitriu et al., 2010 ) also likely favor regeneration, GATA-2 is a vital determinant of stress erythropoiesis. Mechanistically, anemia increased GATA-2 and Scl/TAL-1 expression, which function through E-box-GATA elements at these enhancers, and the classic anemia-responsive cytokine, Epo, stimulated transcription of the respective genes. Furthermore, mitogen-activated protein kinases (p38 and ERKs) induce GATA-2 phosphorylation, which increases transcriptional activation of select target genes (Katsumura et al., 2014 (Katsumura et al., , 2016 . Scl/TAL1 can also be phosphorylated by mitogen-activated protein kinases (Tang et al., 1999) .
Our results point to a multi-component anemia-responsive mechanism involving (1) anemia-dependent induction of transcription factors critical for composite element-containing enhancer function; (2) anemia-dependent alterations in signaling circuitry, which increases enhancer component activities; and (3) acute Epo-responsiveness. Samd14-Enh represents a foundational G2A enhancer and related G2A enhancers constitute an important sector of the HSPC cistrome ( Figure 7B ). Based on the results described here and functional insights of G2A enhancer-containing genes, we propose that G2A enhancers establish a genetic network that uniquely orchestrates red blood cell regeneration in anemia, thereby conferring survival. Samd14-Enh is not required for steady-state hematopoiesis, illustrating how certain E-box-GATA composite elements can have essential functions in the context of stress. It will be instructive to obtain a global perspective of how anemia regulates this sector to generate transcriptional circuits/networks that enable and/or drive massive red blood cell regeneration and survival in anemia. One would predict that these networks are defective in pathologies of ineffective erythropoiesis and will provide opportunities to overcome limitations to red blood cell production in these contexts.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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Stress Erythropoiesis Signaling Co-integration (Dumitriu et al., 2010; Koulnis et al., 2012 collection), and hematologic parameters measured on a HemaVet complete blood count (CBC) instrument. Phlebotomy was induced by 3 daily bleedings (400 ml) collected retro-orbitally, in conjunction with intraperitoneal injections of 400 ml PBS. Unless otherwise stated, spleens were harvested 3 days post-PHZ injection or post-phlebotomy. Bone marrow transplantation assays were conducted using 5x10 5 bone marrow mononuclear cells transplanted into the retro-orbital sinus of lethally-irradiated (9.5-Gy) B6.SJL-Ptprc a Pep3 b /BoyJ recipient mice (Harandi et al., 2010) . CFU assays in PHZ-treated spleens were conducted using 0.3 ml spleen suspension at 1 x 10 6 cells/ml mixed with 3 ml of Epo-only MethoCultÔ M3334, or Epo, SCF, IL-3 and IL-6 Methocult M3434 (STEMCELL Technologies), and 1.1 ml was plated in replicate 35 mm dishes. BFU-E colonies were counted 5 days after culturing. CFU-E colonies were counted 2 days after plating.
Quantitation of mRNA and Allele-Specific Primary Transcripts Total RNA was purified from 2-30 x 10 6 cells in 1 ml TRIzol (Life Technologies). For primary transcripts, RNA was subjected to on-column DNase treatment at 25 C for 10 min followed by column purification (Qiagen RNeasy). To synthesize cDNA, 2 mg RNA was incubated with 250 ng of random hexamer and oligo(dT) primers preheated at 68 C for 10 min. RNA was incubated with reverse transcriptase (Life Technologies) with 10 mM dithiothreitol (DTT), RNAsin (Promega), and 0.5 mM deoxynucleoside triphosphates at 42
C for 1 h, and then heat inactivated at 98 C for 5 min. Real-time RT-PCR reactions contain 2 ml of cDNA, 10 ml SYBR Green (Applied Biosystems), and 100-500 nM of the appropriate primers, and each biological replicate sample was analyzed in duplicate on a ViiA 7 real-time PCR instrument (Applied Biosystems). Relative expression levels were determined using a standard curve of serial dilutions from appropriate control cDNA (for mRNA analysis) or sonicated genomic DNA (for allele-specific primary transcript analysis) for each primer pair. Negative control cDNA reactions were performed on samples lacking reverse transcriptase. cDNA samples lacking the mutant or WT allele sequence were used as negative controls for each allele-specific primer pair.
Apoptosis and Proliferation Analysis
To assess apoptosis, 1x10 7 cells isolated from control or PHZ-treated spleen were washed with PBS, stained using PE-conjugated CD71 and APC-conjugated Ter119, followed by a wash with 1x Annexin binding buffer (Life Technologies). Cells were resuspended in 100 ml Annexin binding buffer and labeled with 5 ml Annexin V-Alexa Fluor 350 conjugate (Life Technologies) and DRAQ7 TM (eBiosciences). To assess proliferation, total spleen was bead sorted into Ter119 + and Ter119 -fractions using biotin-conjugated antiTer119 antibody and magnetic beads (STEMCELL Technologies). Cells were fixed in 2% paraformaldehyde for 10 min at 37 C and permeabilized in 95% methanol overnight at -20 C. Cells were washed in PBS, blocked in 4%FBS, and stained using PE-conjugated CD71, APC-conjugated Ki67, and DAPI. Data was collected on an LSRII cytometer (BD Biosciences).
Phospho-Flow Cytometry
Splenocytes were Ter119-depleted using biotin-conjugated anti-Ter119 antibody and magnetic beads (STEMCELL Technologies), serum-starved for 1 h in 1% BSA/IMDM at 37 C and treated with 10ng/uL SCF or vehicle 10 min. Cells were immediately fixed in 2% paraformaldehyde for 10 min at 37 C and permeabilized in 95% methanol overnight at -20 C. Cells were stained with rabbit antibodies against phospho (S473)-AKT (p-AKT) and phospho (Thr202/Tyr204) p44/42 ERK1/2 (p-ERK) (9271, 9101; Cell Signaling) for 30 min, then incubated in APC-conjugated goat anti-rabbit (1:200), PE-Cy7-conjugated c-Kit (1:100) and PE-conjugated CD71 (1:100) for 30 min at room temperature. Zombie UV (Biolegend) dye discriminated dead cells. Samples were analyzed using a BD LSR II (BD Biosciences).
Mass Spectrometry 1 x 10
6 cells from WT and Samd14-Enh -/-spleen were resuspended in 300 ml 8 M urea, 100 mM Tris pH 8.0, 10 mM TCEP, and 40 mM chloroacetamide and incubated overnight in 50:1 trypsin prior to fractionation. 48 fractions were collected, each comprising 40 seconds of eluted peptides. Each fraction from the first bioreplicate was analyzed by LC-MS/MS to empirically determine the appropriate targeting window. For each analysis, 30% of the sample was loaded onto a 75 mm i.d. 30 cm long capillary with an imbedded electrospray emitter and packed with 1.7 mm C18 BEH stationary phase. A 3 m/z isolation window was centered on the most abundant isotope, fragmented with 30 NCE HCD collision energy and analyzed in the Orbitrap at 30,000 resolving power. Injection volumes of each sample was normalized based on peptide content. Each raw file was analyzed in Excalibur. The peak height from 3 transitions was recorded, and the mean normalized log 2 peak intensity was averaged for each of three Samd14-specific peptides.
Antibody Generation
Anti-SAMD14 antibodies were generated from purified recombinant Samd14. Full-length mouse Samd14 cDNA was cloned into pET28a for expression of recombinant 6His-SAMD14 in BL21 E. coli induced with 1 mM IPTG for 5 h at 37 C. Recombinant 6His-SAMD14 protein was purified using Ni-NTA agarose (Qiagen) and injected into rabbits (Cocalico Biologicals). Antibodies were purified from serum using a 6His-SAMD14 affinity column and dialyzed overnight into PBS for immediate use.
ChIP and FAIRE GATA-2 ChIP was conducted as described (Im et al., 2004 ). G1E cells (Weiss et al., 1997) containing 1 3 10 7 cells were crosslinked with 1% formaldehyde for 10 min. Anti-GATA-2 rabbit polyclonal antibodies were used with protein A-Sepharose (Sigma) to adsorb immune-specific complexes. Samples were analyzed by real-time PCR. FAIRE was conducted as described (Hewitt et al., 2015; Sanalkumar et al., 2014; Simon et al., 2012) . Cells were fixed with 1% formaldehyde and sonicated to shear the DNA. Following phenol:chloroform extraction of protein-bound DNA, samples were analyzed by real-time PCR relative to input controls.
Epo Stimulation
WT and Samd14-Enh -/-mice were treated with PHZ or vehicle for 3 days. Splenic cells were dissociated, washed in PBS, and serumstarved for 2 h in 1% BSA/IMDM at 37 C. 1 x 10 7 cells were treated with 2U/ml rhEPO or vehicle for 2 , 4 or 12 h. RNA was purified in TRIzol (Invitrogen).
QUANTIFICATION AND STATISTICAL ANALYSIS
For quantitation of mRNA, primary transcript, cell number, cell colonies, CBC and median fluorescence intensities, the results are presented as mean +/-standard error of the mean. Multiple independent cohorts were used in each experiment. Statistical comparisons between two groups were performed using the Students t-test, with a significance cutoff of p < 0.05 (GraphPad Prism). A logrank test was performed on the Kaplan-Meier survival curve (n = 16 in each group) (GraphPad Prism).
